June 1st, 2017
Clinical Trial Participation Update
Find Clinical Trials by State:
National Recruitment: Join NIH Depression Research Studies
Does depression impede your daily life? Are you currently feeling sad and hopeless, experiencing worthlessness and guilt, and have a lack of interest in everyday activities you once enjoyed? NIH studies are investigating the brain and experimental medications (such as ketamine) to rapidly reduce depressive symptoms. Research includes: depressed adults ages 18 to 70, outpatient visits or inpatient stays of up to 12 weeks at the NIH Clinical Center in Bethesda, MD. Call 1-877-MIND-NIH, TTY: 1-866-411-1010, Email: email@example.com.
Join an NIMH Study. Depression research evaluates adults 18-70, the brain and novel medications to rapidly reduce symptoms. http://goo.gl/Se1io5
May 15th, 2017
We also want to call your attention to the latest issue of Outreach Connection, which was emailed to Partners earlier this month. In case you missed the Program’s e-newsletter, you can view the issue here: https://content.govdelivery.com/accounts/USNIMH/bulletins/18e1e1c. Check it out and learn how your fellow Partners are using and disseminating NIMH information!
Have a great day!
NIMH Outreach Partnership Program Staff
May 1st, 2017
Clinical Trial Participation Update
Find Clinical Trials by State:
Nationwide Recruitment: Descriptive Study of Severe Irritability
(Outpatient: 1 day evaluation, and may include follow-up visits until age 25) This study describes, over time, the moods and behavior of children and the associated brain changes. Participants must be in treatment with a physician, medically healthy, and not currently hospitalized, psychotic or suicidal. Symptoms include chronic anger, sadness, or irritability, along with hyperarousal (such as insomnia, distractibility, hyperactivity) and extreme responses to frustration (such as frequent, severe temper tantrums). The study procedures include research and computer tasks, neuropsychological testing and brain imaging. Recruiting ages 7-17. [02-M-0021]
April 15th, 2017
Higher Death Rate Among Youth with First Episode Psychosis: NIH-funded study highlights need for increased early intervention programs
A new study shows that young people experiencing first episode psychosis (FEP) have a much higher death rate than previously thought. Researchers analyzed data on approximately 5,000 individuals aged 16-30 with commercial health insurance who had received a new psychosis diagnosis, and followed them for the next 12 months. They found that the group had a mortality rate at least 24 times greater than the same age group in the general population, in the 12 months after the initial psychosis diagnosis. This study, funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH), underscores that young people experiencing psychosis warrant intensive and proactive treatments, services, and supports.
April 1st, 2017
Join NIH Depression Research Studies
Does depression impede your daily life? Are you currently feeling sad and hopeless, experiencing worthlessness and guilt, and have a lack of interest in everyday activities you once enjoyed? NIH studies are investigating the brain and experimental medications (such as ketamine) to rapidly reduce depressive symptoms. Research includes: depressed adults ages 18 to 70, outpatient visits or inpatient stays of up to 12 weeks at the NIH Clinical Center in Bethesda, MD.
Call 1-877-MIND-NIH, TTY: 1-866-411-1010, Email: firstname.lastname@example.org
Join an NIMH Study. Depression research evaluates adults 18-70, the brain and novel medications to rapidly reduce symptoms.
March 1st, 2017
NIMH has posted a new web page on Integrated Care, which highlights models of integrated care, including collaborative care. You may recall that Dr. Charlene LeFauve noted the effectiveness of the collaborative care model in addressing mental health disparities.
RAISE Investigator John Kane talks about efforts to reduce the duration of untreated psychosis in this Psychiatric Services article. He includes a discussion of the Mindmap project, which was presented by Dr. Vinod Srihari.
February 15th, 2017
Dr. Gordon in the News: Compiles a selection of media interviews with the NIMH Director Joshua Gordon. You can also subscribe to receive email updates about his latest media interviews, news mentions, and commentaries.
Multimedia About Men’s Mental Health: Compiles a series of videos of men discussing their experiences managing depression. The videos were a part of the former Real Men, Real Depression campaign, and have been digitally remastered.
February 1st, 2017
NIMH’s Sarah Lisanby, Director of the Translational Research Division, who presented about device-based advancements for the treatment of refractory depression appeared on the January 17th episode of the nationally syndicated television program The Dr. Oz Show. Dr. Lisanby was invited to appear on-set to discuss electroconvulsive therapy (ECT). The segment included an ECT patient and emphasized the effectiveness and safety of ECT.
Check out this interview with NIMH scientist Carlos Zarate talking about ketamine and its role in identifying fast-acting treatments for depressant.
During the breakout session on addressing mental health in criminal justice settings, the Stepping Up Initiative was noted as a national initiative encourage counties to take steps to reduce the number of people with mental illnesses in jail. Stepping Up released its 2017 technical assistance plan for regular webinars and calls with communities along with the report, Reducing the Number of People with Mental Illnesses in Jail: Six Questions County Leaders Need To Ask.
January 15th, 2017
In his latest Director’s Message, Neural Circuits Research: How and Why, NIMH Director Dr. Gordon talks about the potential pay-offs of research on neural circuits and next steps for going forward. He provides more details about this approach in a Nature Neuroscientist article on Being a Circuit Psychiatrist.
A recent NIH lecture of NIMH’s Bob Heinssen providing an overview of the RAISE findings and evidence-based care for first-episode psychosis has been archived online here. Dr. Heinssen was paired with NIMH investigator Dr. Dwight Dickinson who discussed the nature and treatment of cognitive impairment of schizophrenia.
For those interested in learning more about the NIMH Research Domain Criteria (RDoC) initiative, plan to watch an upcoming
NIH lecture about RDOC and what it means for mental health disorders. The lecture is scheduled for January 25 at noon and will be available via videocast.
December Events, 2016
The NIMH Intramural Research Program is hosting three webinars in January to share both research developments and what trials are being conducted at NIMH, including a new study on depression in teenagers during a January 19 webinar. In addition, Kalene Dehaut, who many of you have meet at Partner meetings, will provide an overview of the basics of clinical research, covering the process and why it is important in the January 23 webinar. We hope you will join us!
December 15, 2016 (Year-End Update)
Attached is the final Update for 2016. The Update will be on hiatus for January 1, and will return January 15, 2017. In case you missed it, the Fall issue of Outreach Connection was emailed to partners earlier this week: https://content.govdelivery.com/accounts/USNIMH/bulletins/170d02f. Read about all the great outreach efforts of your fellow partners!
We also want to call your attention to new RAISE-related resources that may be useful in your outreach efforts to educate the public about first episode psychosis (FEP).
- Two new papers have been published from the RAISE study:
o The RAISE Connection Program: Psychopharmacological Treatment of People with a First Episode of Schizophrenia, Kreyenbuhl, J.A., et al. Psychiatric Services
o Family Member Engagement with Early Psychosis Specialty Care, Lucksted, A., et al. Early Intervention Psychiatry
Links to the abstracts are available on the RAISE website at https://www.nimh.nih.gov/health/topics/schizophrenia/raise/published-articles.shtml
- In addition, the National Association of State Mental Health Program Directors (NASMHPD) in collaboration with SAMHSA has recently hosted webinars on the use of cultural competence practices and addressing suicidal ideation and behavior in Coordinated Specialty Care programs for FEP. They also hosted a webinar reviewing new technical assistance materials for FEP programsavailable on the NASMHPD website.
Finally, you may be interested in a new interview with NIMH Director Joshua Gordon about autism research: https://spectrumnews.org/opinion/q-and-a/questions-joshua-gordon-circuit-solutions-autism/
Wishing you and your families a warm and safe holiday season and the best for the New Year!
NIMH Outreach Partnership Program Staff
November 15, 2016
We wanted to note a new NIMH feature, the Director’s Message from NIMH Director Joshua Gordon. In this first message, he talks about his plans for his first year as NIMH director and his priorities for research: https://www.nimh.nih.gov/about/director/messages/2016/freshman-year.shtml.
We also wanted to let you know that the NIH record, an internal NIH newsletter, published a story about the NIMH Outreach Partnership Program’s recent Annual Meeting. The story describes the panel on addressing disparities in accessing mental health care: https://nihrecord.nih.gov/newsletters/2016/11_04_2016/story6.htm. Thanks to everyone who participated in this session!
June 15, 2016
Clinical Trial Participation Update – Find Clinical Trials by State
Bipolar Disorder (Pediatric) Research Study | Treatment of Severe Mood Dysregulation, SMD
(Inpatient: 12- to 15 weeks) This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy and not currently hospitalized, psychotic or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]http://www.nimh.nih.gov/labs-
For more information on research conducted by the National Institute of Mental Health in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.
NIMH Partner Information
The Outreach Partnership Program is a nationwide initiative of the National Institute of Mental Health’s (NIMH) Office of Constituency Relations and Public Liaison (OCRPL). The Program works to increase the public’s access to science-based mental health information through partnerships with national and state organizations. The Program encourages efforts to reach diverse racial and ethnic groups. The Program also strives to enhance opportunities for the public to benefit from participation in research. These partnerships provide NIMH with the opportunity to engage community organizations in dialogue to better understand the needs, questions, and concerns of those intended to benefit from the research the Institute supports. (from http://www.nimh.nih.gov)
May 15, 2016
The Update includes a review on early psychosis by the Pathways to Positive Futures Research and Training Center. NIMH staff have authored an article in this review on the expansion of Coordinated Specialty Care for First-Episode Psychosis in the U.S.